Document is current
Any future updates will be listed below
-
Authors
Ehrman, Robert R. https://orcid.org/0000-0001-9730-8471
Bredell, Bryce X.
Harrison, Nicholas E.
Favot, Mark J.
Haber, Brian D.
Welch, Robert D.
Levy, Philip D.
Sherwin, Robert L.
-
Funding
Funding for this research was provided by:
Society for Academic Emergency Medicine (RF2017-001)
- License Information
-
More Information
Article History
Received: 5 March 2022
Accepted: 19 July 2022
First Online: 28 July 2022
Declarations
:
: The study was approved by the local Institutional Review Board (MP1 committee, protocol #1602014673) and performed in accordance with the standards of the Declaration of Helsinki. Written informed consent was obtained from patients or a legally authorized representative.
: Not applicable.
: PDL is a member of the American College of Cardiology NCDR Oversight Committee and has served as a consultant for Astra Zeneca, BMS, Cardionomics, Novartis, Siemens, Quidel, Roche Diagnostics, Ortho Diagnostics, Beckman Coulter, Baim Institute, and Patient Insight, and has received funding for research from Novartis, Pfizer, CardioSounds, and Edwards Lifesciences. In addition he has ownership interest in On Sight Medical, Mespere and Emergencies in Medicine. RLS has received grants and/or consulting fees from the companies/organizations: AHRQ, Atobiox, Inc., Allergan Sales, LLC, Medpace, Inc., Rapid Pathogen Screening, Inc, Ashahi Kasei Pharma America, Edwards Lifesciences. NEH received grant support from the Blue Cross/Blue Shield Foundation of Michigan (Grant# 25TCJ). The other authors disclose that they have no competing interests.
